• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market Update + Government Shutdown Nears End After 42 Days

    11/11/25 8:55:00 AM ET
    $ANRO
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $ANRO alert in real time by email

    NEW YORK, Nov. 11, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Kristen Scholer delivers the pre-market update on November 11th

    • Stocks opened slightly lower Tuesday after a strong global rally pushed the S&P 500 up 1.5% to start the week, fueled by optimism that the longest U.S. government shutdown could end soon.
    • The Senate passed a temporary funding bill late Monday to keep most of the government running through January; the House vote is next, followed by President Trump's expected signature.
    • Tech stocks led early gains, but momentum faded amid valuation concerns—highlighted by SoftBank selling its entire stake in Nvidia, sending shares down nearly 1%.

    Opening Bell

    Alto Neuroscience (NYSE:ANRO) rings the Opening Bell

    Closing Bell

    Academy Asset Management marks the 2-year anniversary of the Academy Veteran Bond ETF (VETZ)

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--government-shutdown-nears-end-after-42-days-302611624.html

    SOURCE New York Stock Exchange

    Get the next $ANRO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANRO
    $ICE

    CompanyDatePrice TargetRatingAnalyst
    Alto Neuroscience Inc.
    $ANRO
    11/17/2025Buy
    BTIG Research
    Intercontinental Exchange Inc.
    $ICE
    10/13/2025$210.00Outperform → Strong Buy
    Raymond James
    Alto Neuroscience Inc.
    $ANRO
    9/29/2025$15.00Buy
    Chardan Capital Markets
    Alto Neuroscience Inc.
    $ANRO
    10/23/2024$29.00 → $4.00Outperform → Neutral
    Wedbush
    Alto Neuroscience Inc.
    $ANRO
    10/23/2024Buy → Neutral
    Rodman & Renshaw
    Intercontinental Exchange Inc.
    $ICE
    10/14/2024$185.00Strong Buy → Outperform
    Raymond James
    Intercontinental Exchange Inc.
    $ICE
    9/27/2024$200.00Outperform
    RBC Capital Mkts
    Intercontinental Exchange Inc.
    $ICE
    9/26/2024$182.00Buy
    TD Cowen
    More analyst ratings

    $ANRO
    $ICE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Alto Neuroscience

    BTIG Research initiated coverage of Alto Neuroscience with a rating of Buy

    11/17/25 9:40:20 AM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Intercontinental Exchange upgraded by Raymond James with a new price target

    Raymond James upgraded Intercontinental Exchange from Outperform to Strong Buy and set a new price target of $210.00

    10/13/25 8:40:25 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Chardan Capital Markets initiated coverage on Alto Neuroscience with a new price target

    Chardan Capital Markets initiated coverage of Alto Neuroscience with a rating of Buy and set a new price target of $15.00

    9/29/25 9:57:16 AM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANRO
    $ICE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Kapani Mayur exercised 5,345 shares at a strike of $57.31 and sold $837,382 worth of shares (5,345 units at $156.67) (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    12/10/25 4:30:17 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Director Sprieser Judith A sold $584,440 worth of shares (3,700 units at $157.96), decreasing direct ownership by 20% to 14,469 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    12/9/25 4:30:04 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    President, NYSE Group Martin Lynn C gifted 396 shares, decreasing direct ownership by 0.67% to 59,033 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    12/8/25 4:30:08 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ANRO
    $ICE
    SEC Filings

    View All

    SEC Form 144 filed by Intercontinental Exchange Inc.

    144 - Intercontinental Exchange, Inc. (0001571949) (Subject)

    12/5/25 4:24:53 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Intercontinental Exchange Inc.

    SCHEDULE 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    12/3/25 11:12:52 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 144 filed by Intercontinental Exchange Inc.

    144 - Intercontinental Exchange, Inc. (0001571949) (Subject)

    11/20/25 4:23:24 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ANRO
    $ICE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ANRO
    $ICE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    NYSE Content Advisory: Pre-Market Update + Magnum is World's Largest Ice Cream Business after Spinoff

    NEW YORK, Dec. 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on December 10th Stocks are little changed as traders await the Federal Reserve's final policy announcement of the year, with uncertainty around next year's interest rate path amid a weakening jobs market and persistent inflation.Magnum Ice Cream (NYSE:MICC) is set to ring the Opening Bell. The Amsterdam-based ice cream giant recently spun off from NYSE-listed Unilever. The company owns bra

    12/10/25 8:55:00 AM ET
    $ICE
    $MICC
    Investment Bankers/Brokers/Service
    Finance
    Specialty Foods
    Consumer Staples

    NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York

    NEW YORK, Dec. 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily market update directly from the NYSE Trading Floor. Access today's NYSE market update for market insights as trading begins.  Kristen Scholer delivers the market update on December 9th Traders await the Federal Reserve's final interest rate decision of the year. Markets are pricing in with near certainty a 0.25% rate cut, following the Fed's two-day policy meeting that begins today, with the announcement expected Wednesday.NYSE-listed Target unveils a reimagined SoHo store led by incoming CEO Michael Fiddelke. The concept includes a beauty bar, selfie checkout, and curated

    12/9/25 11:38:00 AM ET
    $AUB
    $ICE
    Major Banks
    Finance
    Investment Bankers/Brokers/Service

    Expero to Deliver ICE's Market Data Through Digital Experiences

    This collaboration expands Expero's Connected Finance ecosystem with ICE's cross-asset data and analytics to power modern investor and advisor platforms HOUSTON, Dec. 9, 2025 /PRNewswire/ -- Expero, a leader in digital wealth technology and AI-driven user experiences, today announced an agreement with Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, to bring ICE's extensive cross-asset data and analytics into Expero's Connected Finance platform, enabling clients to integrate market data directly into trading, advisor and investor workflows using Expero's custom-built software components.

    12/9/25 8:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    CHIEF MEDICAL OFFICER Savitz Adam bought $190,833 worth of shares (15,000 units at $12.72) (SEC Form 4)

    4 - Alto Neuroscience, Inc. (0001999480) (Issuer)

    7/11/24 4:15:04 PM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Smith Nicholas Conrad bought $100,628 worth of shares (6,150 units at $16.36), increasing direct ownership by 30% to 26,866 units (SEC Form 4)

    4 - Alto Neuroscience, Inc. (0001999480) (Issuer)

    4/1/24 4:15:30 PM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANRO
    $ICE
    Leadership Updates

    Live Leadership Updates

    View All

    Lord Hill of Oareford Elected to Board of Directors of Intercontinental Exchange

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its Board of Directors has elected The Rt. Hon. the Lord Hill of Oareford CBE (Lord Hill) as a new director, effective September 18, 2025. Lord Hill, who currently serves on the Board of Directors of ICE Endex Markets, a subsidiary of ICE, is also expected to join the Board of Directors of ICE Futures Europe subject to regulatory approval. "On behalf of the Board, I am pleased to welcome our colleague, Lord Hill, to his expanded role at ICE," said Jeffrey C. Sprecher, Founder, Chair and CEO of Intercontinental Exchange. "Lord Hill brings tremendous depth and breadth of experi

    9/18/25 4:15:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 22nd Markets are closely watching the Fed's economic policy symposium in Jackson Hole, where Chair Jerome Powell will speak at 10 a.m. ET.Nearly 70% of traders expect a Fed rate cut in September amid dual concerns about inflation and employment highlighted in the Fed's July meeting minutes.The Fed's July meeting minutes emphasized policymakers' concerns about both inflation ris

    8/22/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Alto Neuroscience Appoints Biotech Industry Veteran, Raymond Sanchez, M.D., to Its Board of Directors

    Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the appointment of Raymond Sanchez, M.D., to its Board of Directors, effective August 12, 2025. Dr. Sanchez is a highly accomplished executive with a strong background in medicine and over 20 years of strategic experience in the life sciences industries. "We are delighted to welcome Ray to our Board of Directors as we continue advancing multiple clinical-stage precision psychiatry programs," said Amit Etkin, M.D., Ph.D., founder and chief executive officer of Alto Neuroscience. "Ray brings an impress

    8/13/25 8:03:00 AM ET
    $ANRO
    $CERE
    $RAPP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANRO
    $ICE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alto Neuroscience Inc.

    SC 13G/A - Alto Neuroscience, Inc. (0001999480) (Subject)

    11/14/24 5:46:11 PM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Alto Neuroscience Inc.

    SC 13G - Alto Neuroscience, Inc. (0001999480) (Subject)

    11/14/24 7:00:29 AM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Alto Neuroscience Inc.

    SC 13G - Alto Neuroscience, Inc. (0001999480) (Subject)

    11/12/24 9:50:14 AM ET
    $ANRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANRO
    $ICE
    Financials

    Live finance-specific insights

    View All

    NYSE Content Advisory: Pre-Market Update + Magnum is World's Largest Ice Cream Business after Spinoff

    NEW YORK, Dec. 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on December 10th Stocks are little changed as traders await the Federal Reserve's final policy announcement of the year, with uncertainty around next year's interest rate path amid a weakening jobs market and persistent inflation.Magnum Ice Cream (NYSE:MICC) is set to ring the Opening Bell. The Amsterdam-based ice cream giant recently spun off from NYSE-listed Unilever. The company owns bra

    12/10/25 8:55:00 AM ET
    $ICE
    $MICC
    Investment Bankers/Brokers/Service
    Finance
    Specialty Foods
    Consumer Staples

    Intercontinental Exchange Approves Fourth Quarter Dividend of $0.48 per Share

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, announced today a $0.48 per share dividend for the fourth quarter of 2025, which is up 7% from the $0.45 per share dividend paid in the fourth quarter of 2024. The cash dividend is payable on December 31, 2025 to stockholders of record as of December 16, 2025. The ex-dividend date is December 16, 2025. About Intercontinental Exchange Intercontinental Exchange, Inc. (NYSE:ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-c

    10/30/25 7:35:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange Reports Strong Third Quarter 2025

    Intercontinental Exchange (NYSE:ICE): 3Q25 net revenues of $2.4 billion, +3% y/y   3Q25 GAAP diluted earnings per share (EPS) of $1.42, +25% y/y   3Q25 adj. diluted EPS of $1.71, +10% y/y   3Q25 operating income of $1.2 billion, +6% y/y; adj. operating income of $1.4 billion, +3% y/y   3Q25 operating margin of 49%; adj. operating margin of 59%   Through September 30, 2025, returned over $1.7 billion to stockholders, including $894 million in share repurchases   Jeffrey C. Sprecher,ICE Chair & Chief Executive Officer, said,"We are pleased to report our third quarter results, which extend our track record of revenue and earnings per

    10/30/25 7:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance